Objective: The 2nd to 4th digit length (2D:4D) is inversely related to androgen exposure during the fetal period, which may represent a risk factor for several steroid-related diseases. We aimed to evaluate the relationship between 2D:4D ratio and the risk of developing prostate cancer (PCa). Subjects and Methods: We assessed the 2D:4D ratio of 474 men >40 years old, stratified into three groups: group 1 (n = 222) patients with PCa, group 2 (n = 82) subjects with high risk of PCa, and group 3 (n = 170) men with low risk of PCa. Subjects were submitted to a digital picture of the ventral surface of the right hand and 2nd and 4th fingers measurements were determined by the distance from the proximal crease to the tip using computer-assisted analysis. Results: The mean serum prostate-specific antigen level was 7.5 ng/ml in the high-risk group and 0.92 ng/ml in the low-risk group (p < 0.05). The mean 2D:4D ratios were 0.96 ± 0.04, 0.97 ± 0.04 and 0.96 ± 0.04 for the PCa, high-risk and low-risk groups, respectively, and no difference was found among the three groups (p = 0.12). Conclusion: Anthropometry of the hand using the 2D:4D ratio is not a predictor of PCa.

Keywords:
Prostate cancer, 2D:4D ratio, Digit ratio, 2nd to 4th digit length, Prostate neoplasm
1.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statistics. CA Cancer J Clin 2008;58:71-96.
2.
Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, et al: Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst 2012;104:125-132.
3.
Goering W, Kloth M, Schulz WA: DNA methylation changes in prostate cancer. Methods Mol Biol 2012;863:47-66.
4.
Marberger M, Barentsz J, Emberton M, Hugosson J, Loeb S, Klotz L, Koch M, Shariat SF, Vickers A: Novel approaches to improve prostate cancer diagnosis and management in early-stage disease. BJU Int 2012;109(suppl 2):1-7.
5.
Zhu S, Zhang H, Tang Y, Wang J: Polymorphisms in XPD and hOGG1 and prostate cancer risk: a meta-analysis. Urol Int 2012;89:233-240.
6.
Zhang H, Xu Y, Li L, Liu R, Ma B: The interleukin-6 -174 G/C polymorphism and prostate cancer risk: a systematic review and meta-analysis. Urol Int 2012;88:447-453.
7.
Prins GS, Birch L, Tang WY, Ho SM: Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reprod Toxicol 2007;23:374-382.
8.
Van de Beek C, Thijssen JH, Cohen-Kettenis PT, van Goozen SH, Buitelaar JK: Relationships between sex hormones assessed in amniotic fluid, and maternal and umbilical cord serum: what is the best source of information to investigate the effects of fetal hormonal exposure? Horm Behav 2004;46:663-669.
9.
McIntyre MH: The use of digit ratios as markers for perinatal androgen action. Reprod Biol Endocrinol 2006;4:10-19.
10.
Kondo T, Zákány J, Innis JW, Duboule D: Of fingers, toes and penises. Nature 1997;390:29.
11.
Lutchmaya S, Baron-Cohen S, Raggatt P, Knickmeyer R, Manning JT: 2nd to 4th digit ratios, fetal testosterone and estradiol. Early Hum Dev 2004;77:23-28.
12.
Malas MA, Dogan S, Evcil EH, Desdicioglu K: Fetal development of the hand, digits and digit ratio (2D:4D). Early Hum Dev 2006;82:469-475.
13.
Hönekopp J, Watson S: Meta-analysis of digit ratio 2D:4D shows greater sex difference in the right hand. Am J Hum Biol 2010;22:619-630.
14.
Manning JT, Scutt D, Wilson J, Lewis-Jones DI: The ratio of 2nd to 4th digit length: a predictor of sperm numbers and concentrations of testosterone, luteinizing hormone and oestrogen. Hum Reprod 1998;13:3000-3004.
15.
Trivers R, Manning J, Jacobson A: A longitudinal study of digit ratio (2D:4D) and other finger ratios in Jamaican children. Horm Behav 2006;49:150-156.
16.
Brown WM, Hines M, Fane BA, Breedlove SM: Masculinized finger length patterns in human males and females with congenital adrenal hyperplasia. Horm Behav 2002;42:380-386.
17.
Okten A, Kalyoncu M, Yariş N: The ratio of second-and fourth-digit lengths and congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Early Hum Dev 2002;70:47-54.
18.
Choi IH, Kim KH, Jung H, Yoon SJ, Kim SW, Kim TB: Second to fourth digit ratio: a predictor of adult penile length. Asian J Androl 2011;13:710-714.
19.
Manning JT, Leinster S: The ratio of 2nd to 4th digit length and age at presentation of breast cancer: a link with prenatal oestrogen? Breast 2001;10:355-357.
20.
Successful Traders: The Testosterone Effect. Time, January 12, 2009. http://www.time.com/time/business/article/0,8599,1871066,00.html (accessed March 27, 2012).
21.
Jung H, Kim KH, Yoon SJ, Kim TB: Second to fourth digit ratio: a predictor of prostate-specific antigen level and the presence of prostate cancer. BJU Int 2011;107:591-596.
22.
Muller DC, Giles GG, Manning JT, Hopper JL, English DR, Severi G: Second to fourth digit ratio (2D:4D) and prostate cancer risk in the Melbourne Collaborative Cohort Study. Br J Cancer 2011;105:438-440.
23.
Rahman AA, Lophatananon A, Stewart-Brown S, Harriss D, Anderson J, Parker T, et al: Hand pattern indicates prostate cancer risk. Br J Cancer 2011;104:175-177.
24.
Fleshner NE, Lawrentschuk N: Risk of developing prostate cancer in the future: overview of prognostic biomarkers. Urology 2009;73(5 suppl):S21-S27.
25.
Schröder FH, Roobol MJ, Andriole GL, Fleshner N: Defining increased future risk for prostate cancer: evidence from a population based screening cohort. J Urol 2009;181:69-74.
26.
Hönekopp J, Manning JT, Müller C: Digit ratio (2D:4D) and physical fitness in males and females: evidence for effects of prenatal androgens on sexually selected traits. Horm Behav 2006;49:545-549.
27.
Pokrywka L, Rachoń D, Suchecka-Rachoń K, Bitel L: The second to fourth digit ratio in elite and non-elite female athletes. Am J Hum Biol 2005;17:796-800.
28.
Allaway HC, Bloski TG, Pierson RA, Lujan ME: Digit ratios (2D:4D) determined by computer-assisted analysis are more reliable than those using physical measurements, photocopies, and printed scans. Am J Hum Biol 2009;21:365-370.
29.
García-Cruz E, Piqueras M, Huguet J, Ribal MJ, Vilaseca A, Gosálbez D, Castañeda-Argáiz R, Carrión A, Alcover J, Alcaraz A: Higher second fourth digit ratio predicts higher incidence of prostate cancer in prostate biopsy. Arch Esp Urol 2012;65:816-821.
30.
Oh JK, Kim KH, Jung H, Yoon SJ, Kim TB: Second to fourth digit ratio: its relationship with core cancer volume and Gleason score in prostate biopsy. Int Braz J Urol 2012;38:611-619.
31.
Waters M, Rebholz CM, Wood B, Kuske A, McIntyre M, Sartor O: Second to fourth digit ratio and prostate cancer severity. Prostate Cancer Prostatic Dis 2013;16:107-110.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.